APA
Al-Mulla F., Bitar M. S., Thiery J. P., Zea T. T., Chatterjee D., Bennett L., Park S., Edwards J. & Yeung K. C. (20131113). Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer. : American journal of cancer research.
Chicago
Al-Mulla Fahd, Bitar Milad S, Thiery Jean Paul, Zea Tan Tuan, Chatterjee Devasis, Bennett Lindsay, Park Sungdae, Edwards Joanne and Yeung Kam C. 20131113. Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer. : American journal of cancer research.
Harvard
Al-Mulla F., Bitar M. S., Thiery J. P., Zea T. T., Chatterjee D., Bennett L., Park S., Edwards J. and Yeung K. C. (20131113). Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer. : American journal of cancer research.
MLA
Al-Mulla Fahd, Bitar Milad S, Thiery Jean Paul, Zea Tan Tuan, Chatterjee Devasis, Bennett Lindsay, Park Sungdae, Edwards Joanne and Yeung Kam C. Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer. : American journal of cancer research. 20131113.